 <p><b>Protecting Access to Affordable Medicines Act of </b><b>2021</b></p> <p>This bill prohibits additional rebates for certain drugs under the Medicaid Drug Rebate Program. Specifically, the bill prohibits additional rebates with respect to noninnovator multiple-source drugs (i.e., generics) for which the average manufacturer price is less than $1. </p>